Use of gelatine capsules for application of methamphetamine: a new harm reduction approach
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
21242079
DOI
10.1016/j.drugpo.2010.12.001
PII: S0955-3959(10)00169-6
Knihovny.cz E-resources
- MeSH
- Administration, Oral MeSH
- Chemistry, Pharmaceutical MeSH
- Program Evaluation MeSH
- Injections, Intravenous MeSH
- Substance Abuse, Intravenous prevention & control MeSH
- Humans MeSH
- Methamphetamine administration & dosage adverse effects chemistry MeSH
- Excipients chemistry MeSH
- Amphetamine-Related Disorders rehabilitation MeSH
- Drug Compounding MeSH
- Surveys and Questionnaires MeSH
- Harm Reduction * MeSH
- Central Nervous System Stimulants administration & dosage adverse effects chemistry MeSH
- Capsules MeSH
- Gelatin chemistry MeSH
- Focus Groups MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- Methamphetamine MeSH
- Excipients MeSH
- Central Nervous System Stimulants MeSH
- Capsules MeSH
- Gelatin MeSH
BACKGROUND: In order to reduce injecting drug use, low-threshold facilities in the Czech Republic have started to distribute empty gelatine capsules as an oral alternative of drug application for those injecting methamphetamine. This report reviews implementation of this intervention and its possible benefits and limitations. METHODS: Between December 2008 and January 2009, 109 low-threshold facilities were asked to complete a questionnaire about the capsule programmes. Two focus groups were conducted, one with professionals involved in distribution and one with peer outreach workers who were interviewed on their experience of using the capsules. RESULTS: A total of 50 facilities (46%) responded to the questionnaire; 16 (32%) distributed the capsules regularly and 19 (38%) were planning to introduce this practice. The main target groups were injecting users of methamphetamine whose veins had been damaged, and methamphetamine users wishing to reduce injecting. The advantages of capsules, as perceived by service staff and peer outreach workers, were their easy use and the satisfactory effect of the oral application; health risks related to the oral use of methamphetamine were considered drawbacks. CONCLUSION: Capsule distribution is a promising harm reduction approach for injectors of methamphetamine or other stimulants; nonetheless its benefits and limitations should be further analysed in an in-depth longitudinal study.
References provided by Crossref.org
Understanding the crisis in harm reduction funding in Central and Eastern Europe